Skip to content

Drug interactions

Ezetimibe + Glecaprevir / pibrentasvir

Severity: Moderate

Ezetimibe and Glecaprevir / pibrentasvir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glecaprevir and pibrentasvir inhibit hepatic uptake transporters and may raise ezetimibe plasma concentrations. The increase is probably of limited clinical consequence, but ezetimibe adverse effects such as myalgia or liver enzyme elevation could be more likely.

What this interaction means in plain words

Ezetimibe and Glecaprevir / pibrentasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Inhibition of OATP1B1/1B3 uptake transporters by glecaprevir and pibrentasvir reduces hepatic clearance of ezetimibe.

What to do

Monitor for muscle symptoms and liver enzyme abnormalities during the HCV treatment course. No empirical dose change is required.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ezetimibe and Glecaprevir / pibrentasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ezetimibe with Glecaprevir / pibrentasvir?

MediHelp rates the interaction as moderate. Ezetimibe and Glecaprevir / pibrentasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Glecaprevir and pibrentasvir inhibit hepatic uptake transporters and may raise ezetimibe plasma concentrations. The increase is probably of limited clinical consequence, but ezetimibe adverse effects such as myalgia or liver enzyme elevation could be more likely.

How serious is the interaction between Ezetimibe and Glecaprevir / pibrentasvir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for muscle symptoms and liver enzyme abnormalities during the HCV treatment course. No empirical dose change is required.

What other medicines interact with Ezetimibe?

MediHelp also lists interactions of Ezetimibe with, for example, Apalutamide, Cholestyramine, Cyclosporin. The full list is on the Ezetimibe page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in